The Trip of a Lifetime
DOSED 2 Screening with Dr. Gabor Maté & Dennis McKenna Q&A Mark your calendar – DOSED
July 6, 2022
DOSED 2 Screening with Dr. Gabor Maté & Dennis McKenna Q&A Mark your calendar – DOSED
Enveric Biosciences Expands Portfolio of Drug Development Candidates and Files New Provisional Patent Application NAPLES,
Blackhawk’s MindBio Therapeutics Invests NZ$2.3 Million to Fast Track Psychedelic Microdosing Phase 2 Clinical Trials
Blackhawk Subsidiary Digital Mind Technology Starts Phase 1 Development of Digital Therapeutic Platform and is
Enveric Biosciences and University of Calgary Collaborate on a Groundbreaking Clinical Trial for EVM-101 in
Federal Appeals Court Dismisses Cancer Patients’ Case To Use Psilocybin Under Right-To-Try Laws A lawsuit
B.C.’s functional and psychedelic mushroom industry is having a shroom boom Antidepressants are often ineffective
Blackhawk Growth Fully Funds Phase II Clinical Trials in Psychedelics and Begins Development of Digital
Blackhawk Growth’s MindBio Therapeutics Completes Safety Milestone In Its Phase 1 Clinical Trials Vancouver, British
Blackhawk Growth’s MindBio Therapeutics Looks to Expand Microdosing Clinical Trials Vancouver, British Columbia – November
Agtech and KRTL Biotech Join Forces to Develop and Distribute Unique CBD and Psilocybin Products
Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous
BLACKHAWK GROWTH’S MINDBIO THERAPEUTICS BRINGS DIGITAL MENTAL HEALTH TECHNOLOGY TO PSYCHEDELICS CLINICAL TRIALS Could microdosing
Blackhawk Growth’s MindBio Therapeutics Signs Collaboration Agreement With Digital Mind Technology Vancouver, British Columbia –
Blackhawk Growth’s MindBio Therapeutics Plans to Commercialize Intellectual Property Generated from the University of Auckland’s
Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014,
Blackhawk Growth Subsidiary, MindBio Therapeutics, Accelerates Phase 1 & Phase 2 Microdosing Clinical Trials Vancouver,
Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its Drugs to Differentiate Between
Washington Officials Join Cancer Patients In Federal Court Argument Pushing DEA To Allow Psilocybin Access
Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and
Notice of Allowance Issued for Central Nervous System Peptide Technology You probably know that psilocybin
B.C. health researchers harness the ‘magic’ of psychedelic mushrooms After beating cancer, Mona Strelaeff suffered
Why Is Ottawa Stalling Proven Magic Mushroom Therapy for the Dying? After two psilocybin-assisted therapy
Psilocybin May Reduce Suicidal Thoughts in Terminally Ill Patients, Suggests New Study A recent NYU